Newleos Therapeutics logo

Newleos Therapeutics

Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines.

newleos.com

Company Details

Founded

2024

Employees

Between 10 - 50 employees

Raised

$93,500,000

Public

No

Acquired

No

CEO

David DonabedianDavid Donabedian

Founders

Miguel Sobral
Miguel Sobral
William Martin
William Martin
Federico Bolognani
Federico Bolognani

Company Collections

These are collections Newleos Therapeutics is a part of. Click on the collection name to view similar companies.

Total Amount Raised: $93,500,000

Newleos Therapeutics Funding Rounds

  • Series A

    $93,500,000

    Series A Investors

    Goldman Sachs Alternatives
    Longwood Fund
    Novo Holdings
    DCVC Bio
    Arkin Bio Ventures
Funding info provided by Diffbot.

Newleos Therapeutics Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Newleos Therapeutics.

Recent reviews